Dow Jones
32.560,60 +316,02 (+0,98%) Nasdaq
11.860,11 +184,57 (+1,58%) Nikkei 225
27.459,77 +514,10 (+1,91%) EUR/USD
1,0771 -0,0001 (-0,01%) Bitcoin EUR
26.225,14 +409,22 (+1,59%) CMC Crypto 200
616,46 +11,41 (+1,89%)
Sprott Physical Gold and Silver Trust (0N2R.L)
| Chiusura precedente | 15,88 |
| Aperto | 15,94 |
| Denaro | N/D x N/D |
| Lettera | N/D x N/D |
| Min-Max giorno | 15,94 - 15,94 |
| Intervallo di 52 settimane | 15,94 - 15,94 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | -0,01 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Wellbeing Digital Sciences Announces the Appointment of Natalie Dolphin as VP of Marketing and Investment Relations
Ms. Dolphin is a key strategic addition to the team, and will have an impact on the corporate strategy and growth opportunities of the companyVANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by
- GlobeNewswire
Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (JointAlive®) Supplementation in treating OA
VANCOUVER, British Columbia, June 17, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that a clinical study conducted by its wholly owned subsidiary KGK Sciences Inc. (“KGK”), has shown positive res
